A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer

Yiran Liang(Qilu Hospital of Shandong University), Qifeng Yang(Qilu Hospital of Shandong University), Renbo Guo(Shandong University), Yuting Sang(Qilu Hospital of Shandong University), Hanwen Zhang(Dongguan People’s Hospital), Ning Zhang(Tianjin Children's Hospital), Ying Liu(Qilu Hospital of Shandong University), Bing Chen(Shanghai Medical College of Fudan University), Yaming Li(Qilu Hospital of Shandong University), Xiaojin Song(Qilu Hospital of Shandong University), Wenjing Zhao(Xinjiang Uygur Autonomous Region Product Quality Supervision and Inspection Institute), Lijuan Wang(Xuzhou University of Technology), Yi Duan(University of Science and Technology of China)
Cell Death and Disease
May 11, 2018
10.1038/s41419-018-0582-1
Cited by 121

Related Papers

Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
|Nature|2019|811
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396